1673-422X
2015 Issue 10
Sorafenib inhibits tumor growth through modulating vasculogenic mimicry in a hepatocellular carci-noma xenograft model
Zhang Yueying;,Wang Zhaopeng;,Wang Zhaoxia;,Jia Qing;,Wang Hengxiao;,Jiang Guosheng;,Zhang Weidong;
Zhang Yueying;,Wang Zhaopeng;,Wang Zhaoxia;,Jia Qing;,Wang Hengxiao;,Jiang Guosheng;,Zhang Weidong;
..............page:721-725
Therapeutic effect and prognostic factors for patients with mucoepidermoid carcinoma of parotid gland
Wei Cunzhi;,Cai Defeng;,Qu Jinwen;,Xiao Shiqiang;,Wang Jianhong;
Wei Cunzhi;,Cai Defeng;,Qu Jinwen;,Xiao Shiqiang;,Wang Jianhong;
..............page:726-729
Expressions of MMP-7 and bFGF and their correlations with tumor interstitial microvascular density ;and cancer metastasis in NSCLC
Li Daosheng;,Ban Yuanyuan;
Li Daosheng;,Ban Yuanyuan;
..............page:730-733
Diagnostic analysis of endoscopic Lugol solution staining combined with narrow band imaging for ;esophageal cancer and precancerous lesions
Yang Bin;,Chen Yan;
Yang Bin;,Chen Yan;
..............page:734-737
Evaluation of liver function after G4 cyberknife treatment of large hepatocellular carcinoma
Zhang Jinlong;,Xue Hui;,Liang Xuefeng;,Wan Zhiqing;,Chang Xiaoyun;,Zhang Jian;,Han Ping;,Li Yu;
Zhang Jinlong;,Xue Hui;,Liang Xuefeng;,Wan Zhiqing;,Chang Xiaoyun;,Zhang Jian;,Han Ping;,Li Yu;
..............page:738-742
Meta-analysis of the association between GSTT1 and the susceptibility to colorectal cancer among ;Chinese population
Yang Tianning;,Zhao Da;,Ma Shoucheng;,Guan Quanlin;
Yang Tianning;,Zhao Da;,Ma Shoucheng;,Guan Quanlin;
..............page:743-746
Expression and significance of HA117 gene in tumor
Wang Hong;,Jia Xiuhong;
Wang Hong;,Jia Xiuhong;
..............page:747-749
Mechanism of Raf kinase inhibitor protein down-regulation in cancer
Wang Yun;,Li Yuhong;
Wang Yun;,Li Yuhong;
..............page:750-752
Molecular mechanism and application of translationally controlled tumor protein in tumor targeting ;therapy
Han Yujing;,Li Yilan;,Ning Xuelian;,Sun Huiying;,Zhou Chunshui;
Han Yujing;,Li Yilan;,Ning Xuelian;,Sun Huiying;,Zhou Chunshui;
..............page:753-755
Overview of molecular diagnosis and targeted treatment of tumor
Zheng Xiaowen;,Wang Yuping;,Zhou Yongning;
Zheng Xiaowen;,Wang Yuping;,Zhou Yongning;
..............page:756-758
Progress of phage display technology in cancer
Luo Junqian;,Dong Suming;,Zhang Fan;,Yang Xiaofeng;
Luo Junqian;,Dong Suming;,Zhang Fan;,Yang Xiaofeng;
..............page:759-761
DNA methylation of glioma related gene and its significance
Yan Xiaoguang;,Hua Dingchao;,Guo Geng;,Lu Chenyang;
Yan Xiaoguang;,Hua Dingchao;,Guo Geng;,Lu Chenyang;
..............page:762-765
Roles of UBE2C in breast cancer and its clinical significance
Qin Tao;,Li Man;
Qin Tao;,Li Man;
..............page:766-768
Gemcitabine in combination with chemotherapy in the treatment of recurrent or metastatic breast ;cancer
zuo zhong sheng ;, xu cong ;, wang jin ;
zuo zhong sheng ;, xu cong ;, wang jin ;
..............page:769-772
Stereotactic body radiotherapy for early stage non-small cell lung cancer
Lin Li;,Zhou Fuxiang;
Lin Li;,Zhou Fuxiang;
..............page:773-775
The immunotherapy of lung cancer
Zhang Shujuan;,Chang Jianhua;
Zhang Shujuan;,Chang Jianhua;
..............page:776-779
Research progress of microRNA in gastric cancer
Dou Yue;,Tang Yong;
Dou Yue;,Tang Yong;
..............page:780-782
microRNAs and recurrent hepatocellular carcinoma
Ma Chenyang;,Hu Minghua;
Ma Chenyang;,Hu Minghua;
..............page:783-785
Anti-hepatoma mechanisms of ginsenoside
Zhang Na;,Feng Yinglu;
Zhang Na;,Feng Yinglu;
..............page:786-788
The related factors of endometrial cancer induced by obesity
Zhang Ying;,Sheng Xiugui;
Zhang Ying;,Sheng Xiugui;
..............page:789-792
gu sui zeng sheng yi chang zong he zheng gu sui zeng zhi xing zhong liu bu neng fen lei 1 li
gao sheng hai ;, li bin bin ;, zhou li jun ;
gao sheng hai ;, li bin bin ;, zhou li jun ;
..............page:793-794
Evolution of the thematic structure of oncology based on the co-word analysis
Cheng Xueke;,Su Cheng;
Cheng Xueke;,Su Cheng;
..............page:795-800